DVA · 10-Q · 2026Q2 · Full report

Operating Income and Margins

DAVITA INC. · 2026-08-04 · Importance 49 · Surprise 32 · In source text

Consolidated operating income increased 8.6% year over year to $1.061 billion for the six months ended June 30, 2026, while total segment operating margin increased 5.2% to $1.107 billion. U.S. dialysis operating income increased 4.5% to $1.044 billion, supported by higher revenue and productivity improvements despite higher patient-care costs per treatment. Ancillary-services operating income increased 16.7% year over year, with IKC profitability benefiting from a net increase in shared savings. Corporate administrative support expense declined 39.5% to $45.9 million, primarily because of lower professional fees and long-term incentive compensation.

Key facts

• Operating income for the three months ended June 30, 2026: $579,001 source
• Operating income for the six months ended June 30, 2026: $1,060,893 source
• Total segment operating margin for the three months ended June 30, 2026: $595,026 thousand source
• U.S. dialysis segment operating margin for the three months ended June 30, 2026: $537,976 thousand source
• Consolidated operating income for the three months ended June 30, 2026: $579,001 thousand source
• Other income for the six months ended June 30, 2026 compared to other loss for the six months ended June 30, 2025 was impacted by equity investment losses at Mozarc Medical Holding LLC recognized in 2025 and net gains on other investments in 2026 source
• Equity investment income for six months ended June 30, 2026 increased compared to six months ended June 30, 2025 due to increased profitability at certain nonconsolidated dialysis partnerships source
• Other income (loss), net for the three months ended June 30, 2026: $8,300 thousand source

Impact estimates